Lundbeck US

Lundbeck is a biopharmaceutical company committed to researching, developing and delivering transformative therapies for brain diseases. For more than 70 years, we have been at the forefront of brain research, providing breakthrough therapies to millions of people worldwide. Based in Copenhagen with U.S. headquarters in Deerfield, Ill., a U.S. research hub in La Jolla, Calif., and operations in Bothell, Wash., we are the only global biopharmaceutical company solely focused on the brain. We market a number of medicines for the treatment of psychiatric and neurological disorders, and we have a deep pipeline 100 percent focused on innovative treatments for brain diseases. We are majority-owned by the Lundbeck Foundation, a non-profit foundation focused on brain research. This unique ownership model distinguishes us from other biopharmaceutical companies and allows us to maintain our unwavering focus on brain disorders even while other companies exit this challenging space. At Lundbeck...